A preliminary study of intravenous surfactants in paraplegic dogs: Polymer therapy in canine clinical SCI

Journal of Neurotrauma

Volumn 21, Issue 12, 2004, Pages 1767-1777

  Laverty, Peter H ^a   Leskovar, Alenka ^b   Breur, Gert J ^a   Coates, Joan R ^b   Bergman, Robert L ^b   Widmer, William R ^a   Toombs, James P ^a   Shapiro, Scott ^c   Borgens, Richard B ^a,d  

^a PURDUE UNIVERSITY   (United States)

^b Department of Small Animal Clinical Sciences   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Canine paraplegia; P 188; Paraplegia; Polyethylene glycol; Polymer; Spinal cord injury; Surfactant

Indexed keywords

MACROGOL; POLOXAMER; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOG; EVOKED SOMATOSENSORY RESPONSE; INJECTION; INTERVERTEBRAL DISK HERNIA; NERVE FIBER REGENERATION; NOCICEPTION; NONHUMAN; PARAPLEGIA; PILOT STUDY; SAFETY; SPINAL CORD INJURY; TREATMENT OUTCOME;

ANIMALS; DOG DISEASES; DOGS; INJECTIONS, INTRAVENOUS; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; PARAPLEGIA; POLOXAMER; POLYETHYLENE GLYCOLS; SPINAL CORD INJURIES; SURFACE-ACTIVE AGENTS; THORACIC VERTEBRAE; TREATMENT OUTCOME;

EID: 9744275280     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2004.21.1767     Document Type: Article

References (34)

1. BLIGHT, A.R., TOOMBS, J.P., BAUER, M.S., and WIDMER, W.R. (1991). The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase 1 clinical trial. J. Neurotrauma 8, 103-119.
2. BORGENS, R.B. (2001). Cellular engineering: molecular repair of membranes to rescue cells of the damaged nervous system. Neurosurgery 49, 370-378; discussion 378-379.
3. BORGENS, R.B. (2003). Restoring function to the injured human spinal cord, in: Advances in Anatomy Embryology and Cell Biology. F. Beck, et al. (eds), Springer-Verlag: Heidelberg, pps. 1-155.
4. BORGENS, R.B., TOOMBS, J.P., BLIGHT, A.R., et al. (1993). Effects of applied electric fields on clinical cases of complete paraplegia in dogs. Restor. Neurol. Neurosci. 5, 305-322.
5. BORGENS, R.B., TOOMBS, J.P., BREUR, G., et al. (1999). An imposed oscillating electrical field improves the recovery of function in neurologically complete paraplegic dogs. J. Neurotrauma 16, 639-657.
6. BORGENS, R.B., and SHI, R. (2000). Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J. 14, 27-35.
7. BORGENS, R.B., and BOHNERT, D. (2001). Rapid recovery from spinal cord injury following subcutaneously administered polyethylene glycol. J. Neurosci. Res. 66, 1179-1186.
8. BORGENS, R.B., SHI, R., and BOHNERT, D. (2002). Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol. J. Exp. Biol. 205, 1-12.
9. BORGENS, R.B., BOHNERT, D., DUERSTOCK, B.S., SPOMAR, D., and LEE, R.A. (2004). A subcutaneous tri-block copolymer produces recovery from spinal cord injury. J. Neurosci. Res. 76, 141-154.
10. CARPENTER, C.P., WOODSIDE, M.D., KINKEAD, E.R., KING, J.M., and SULLIVAN, L.J. (1971). Response of dogs to repeated intravenous injection of polyethylene glycol 4000 with notes on excretion and sensitization. Toxicol. Appl. Pharmacol. 18, 35-40.
11. COATES, J.R. (2000). Intervertebral disk disease. Vet. Clin. North Am. Small Anim. Pract. 30, 77-110, vi.
12. COATES, J.R., SORJONEN, D.C., SIMPSON, S.T., et al. (1995). Clinicopathologic effects of a 21-aminosteroid compound (U74389G) and high-dose methylprednisolone on spinal cord function after simulated spinal cord trauma. Vet. Surg. 24, 128-139.
13. DUERSTOCK, B.S., and BORGENS, R.B. (2002). Three-dimentional morphometry of spinal cord injury follow polyethylene glycol treatment. J. Exp. Biol. 205, 13-24.
14. HANSEBOUT, R.R., BLIGHT, A.R., FAWCETT, S., and REDDY, K. (1993). 4-aminopyridine in chronic spinal cord injury: A controlled, double-blind, crossover study in eight patients. J. Neurotrauma 10, 1-18.
15. HANSEN, H.J. (1952). A pathologic-anatomical study on disk degeneration in dog with special reference to the so-called enchondrosis intervertebralis. Acta Orthop. Scand. 11, 1-129.
16. HAYES, K.C., BLIGHT, A.R., POTTER, P.J., ALLAT, R.D., HSICH, J.T.C., WOLFE, D.L., LAM, S., HAMILTON, J.T. (1993). Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Paraplegia 31, 216-224.
17. HOERLEIN, B.F. (1979). Comparative disk disease: man and dog. JAAHA 15, 535-545.
18. LEE, R.C., CANADAY, D.J., and HAMMER, S. M. (1992a). Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock. J. Burn Care Rehabil. 14, 528-540.
19. LEE, R. C., RIVER, L.P., PAN, F.-S., and WOLLMAN, R.S. (1992b). Surfactant-induced sealing of electrpermeabilized skeletal muscle membranes in vitro. Proc. Natl. Acad. Sci. USA 89, 4524-4528.
20. LUO, J., BORGENS, R.B., and SHI, R. (2002). Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J. Neurochem. 83, 1-10.
21. MARKS, J.D., PAN, C.Y., BUSHELL, T., CROMIE, W., and LEE, R.C. (2001). Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection. FASEB J. 15, 1107-1109.
22. MCNALLY, H.A., and BORGENS, R. (2004). Three-dimensional imaging of living and dying neurons with atomic force microscopy. J. Neurocytol. 33, 251-258.
23. MASKARINEC, S.A., HANNIG, J., LEE, R.C., and LEE, K.Y. (2002). Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys. J. 82, 1453-1459.
24. PALMER, J.S., CROMIE, W.J., and LEE, R.C. (1998). Surfactant administration reduces testicular ischemia-reperfusion injury. J. Urol. 159, 2136-2139.
25. POINTILLART, V., PETITJEAN, M.E., WIART, L., et al. (2000). Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord 38, 71-76.
26. PRINCIPE, A.H. (1968). Polyethylene glycols. Studies of absorption, excretion, retention, and identification. J. Forensic Sci. 13, 90-113.
27. SHAFFER, C.B., and CRITCHFIELD, F.H. (1947). The absorption and excretion of the solid polyethylene glycols ("Carbowax" compounds). J. Am. Pharm. Assoc. 36, 152-157.
28. SHAFFER, C.B., CRITCHFlELD, F.H., and CARPENTER, C.P. (1948). Renal excretion and volume distribution of some polyethylene glycols in the dog. Am. J. Phys. 152, 93-99.
29. SHAPIRO, S., BORGENS, R.B., PASCUZZI, R., ROOS, K., GROFF, M., PURVINE, S., RODGERS, R.B., HAGY, S., NELSON, P. (2004). Phase 1 trial of oscillating field stimulation in human complete spinal cord injury. J Neurosurgery (in press).
30. SHI, R., and BORGENS, R.B. (1999). Acute repair of crushed guinea pig spinal cord by polyethylene glycol. J. Neurophysiol. 81, 2406-2414.
31. SHI, R., BORGENS, R.B., and BLIGHT, A.R. (1999). Functional reconnection of severed mammalian spinal cord axons with polyethylene glycol. J. Neurotrauma 16, 727-738.
32. SHORT, D.J., EL MASRY, W.S., and JONES, P.W. (2000). High-dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective. Spinal Cord 38, 273-286.
33. SMYTH, H.F., CARPENTER, C.P., and SHAFFER, C.B. (1947). The toxicity of high molecular weight polyethylene glycols; chronic oral and parenteral administration. J. Am. Pharm. Assoc. 36, 157-160.
34. WORKING, P., NEWMAN, M., JOHNSON, J., and CORNACOFF, J. (1997). Safety of poly (ethylene glycol) and poly (ethylene glycol) derivatives, in Poly (Ethylene Glycol) Chemistry and Biological Applications. J. Milton Harris and S. Zalipsky (eds), American Chemistry Society: Washington, D.C.